Substance Abuse Treatment Prevention and Policy

Papers
(The TQCC of Substance Abuse Treatment Prevention and Policy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Mindfulness-based programs for substance use disorders: a systematic review of manualized treatments59
Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users55
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public hea48
Stigma: how it affects the substance use disorder patient47
Measuring capital in active addiction and recovery: the development of the strengths and barriers recovery scale (SABRS)35
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada32
“Personal recovery depends on NA unity”: an exploratory study on recovery-supportive elements in Narcotics Anonymous Flanders28
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder27
Mental health problems among young people in substance abuse treatment in Sweden27
Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre26
Prevalence of drug use, alcohol consumption, cigarette smoking and measure of socioeconomic-related inequalities of drug use among Iranian people: findings from a national survey26
‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America26
The prevalence and factors associated with alcohol use disorder among people living with HIV/AIDS in Africa: a systematic review and meta-analysis26
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway25
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review25
Substance use disorders in Saudi Arabia: a scoping review24
Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers23
Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study23
Alcohol consumption and its associated factors among pregnant women in Sub-Saharan Africa: a systematic review and meta-analysis' as given in the submission system22
Recent changes in trends of opioid overdose deaths in North America22
“With tramadol, I ride like a Jaguar”: a qualitative study of motivations for non-medical purpose tramadol use among commercial vehicle operators in Kumasi, Ghana21
Validity of self-reported substance use: research setting versus primary health care setting20
A double-edged sword of using opioids and COVID-19: a toxicological view20
20 years of Portuguese drug policy - developments, challenges and the quest for human rights19
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs19
Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection – a systematic review19
Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study18
Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study18
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway18
Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected17
Assessing the impact of a restrictive opioid prescribing law in West Virginia17
The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms17
Gender disparities in opioid treatment progress in methadone versus counseling16
The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromsø study, 1994–201616
Missed opportunity for alcohol use disorder screening and management in primary health care facilities in northern rural Tanzania: a cross-sectional survey16
Implementation of tobacco control measures in the Gulf Cooperation Council countries, 2008–202015
Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis15
Prevalence and associated factors for alcohol use disorder among tuberculosis patients: a systematic review and meta-analysis study15
A scoping review of factors that influence opioid overdose prevention for justice-involved populations15
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study15
Individualized approach to primary prevention of substance use disorder: age-related risks14
Social capital and chemsex initiation in young gay, bisexual, and other men who have sex with men: the pink carpet Y cohort study14
Drug Abstinence Self-Efficacy Scale (DASES): psychometric properties of the Farsi version14
Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study14
Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada14
Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders14
Strategies to promote the implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in healthcare settings: a scoping review13
The relationship between family intimacy and relapse tendency among people who use drugs: a moderated mediation model13
Research led by people who use drugs: centering the expertise of lived experience13
The consequences of regular methamphetamine use in Tehran: qualitative content analysis12
Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients12
“The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV12
Pattern of cigarette smoking: intensity, cessation, and age of beginning: evidence from a cohort study in West of Iran12
Prevalence and factors associated with substance use among street children in Jimma town, Oromiya national regional state, Ethiopia: a community based cross-sectional study11
Associations between parental alcohol problems in childhood and adversities during childhood and later adulthood: a cross-sectional study of 28047 adults from the general population11
Prevalence and perceived importance of racial matching in the psychotherapeutic dyad: a national survey of addictions treatment clinical practices11
Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA11
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 201710
Healthcare cost associations of patients who use illicit drugs in Florida: a retrospective analysis10
Differences in addiction and recovery gains according to gender – gender barriers and specific differences in overall strengths growth10
The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scores10
Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study9
Digital interventions for substance use disorders in young people: rapid review9
Factors associated with substance use disorder treatment completion: a cross-sectional analysis of justice-involved adolescents9
Cyber-ethnography of cannabis marketing on social media9
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators9
Non -fatal overdose among people who inject drugs in Tehran, Iran9
Naloxone availability in independent community pharmacies in Georgia, 20199
A scoping review of school-based indigenous substance use prevention in preteens (7–13 years)9
Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia8
“Setting people up for success and then failure” – health care and service providers’ experiences of using prize-based contingency management8
Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder8
The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder8
Alcohol use and associated factors among adolescent boys and young men in Kampala, Uganda8
Various forms of alcohol use and their predictors among pregnant women in post conflict northern Uganda: a cross sectional study8
Perspectives of illicit marijuana growers and traders on commercial legalisation of marijuana in South Africa: considerations for policy formulation8
Understanding injecting drug use in Afghanistan: A scoping review8
The effects of maternal alcohol consumption during pregnancy on adverse fetal outcomes among pregnant women attending antenatal care at public health facilities in Gondar town, Northwest Ethiopia: a p8
Prevalence and correlates of non-daily and daily cannabis use among persons 15 years and older in South Africa: results of a national survey in 20178
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–20208
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review7
Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran7
Khat induced psychotic disorder: case report7
Alcohol and illicit drug use among young people living with HIV compared to their uninfected peers from the Kenyan coast: prevalence and risk indicators7
COVID 19—impact on substance use treatment utilization and provision in South Africa7
A chart review of substance use screening and related documentation among adolescents in outpatient pediatric clinics: implications for practice7
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada7
Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management7
A review of research-supported group treatments for drug use disorders7
Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts7
Changes in opioid-related deaths following increased access to opioid substitution treatment7
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment7
A review of the public sector substance use disorder treatment and prevention systems in Kenya7
“That’s the whole thing about vaping, it’s custom tasty goodness”: a meta-ethnography of young adults’ perceptions and experiences of e-cigarette use7
Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse7
0.047200918197632